Grand Medical Group® AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

The company entered the pharmaceutical markets in 2002. At the first stage, the main priorities of Grand Medical Group® included the selection of pharmaceutical products covering the needs of modern medicine, formation of a package of such products in view of the principal therapeutic directions, organization of the products manufacture in Western Europe and development of their registration dossiers for further introduction to the market and implementation into practical medicine.

Initially, Grand Medical Group® targeted to introduce modern, effective and practically tested medical products to rapidly developing markets with new methods of therapy actively adopted to the health care system of the CIS countries. In 2012, a new period in the development of the company began: it was reorganized into a group of companies with 4 additional structural units for supervision of special sectors of the common business. Grand Medical Group® AG, Switzerland is directly in charge for strategic coordination and management of all processes between the companies within the general structure.

The company’s portfolio has expanded due to complex products enabling effective and convenient control of a number of most critical pathogenetic factors at the same time. New products developed by Grand Medical Group® should increase the effectiveness of therapy for many significant urological, gynecological, neurological and gastroenterological diseases. New products are actively introduced not only to rapidly developing markets but also to mature markets of Central, Western and Southern Europe and Asia. Currently, GrandMedical Group® operates in Poland, Spain, Turkey, Romania and Albania.

Grand Medical Group® AG is a group of pharmaceutical companies specialized in the development, production, registration and introduction into medical practice of modern innovative products based on organic, synthetic and herbal compounds.

The company entered the pharmaceutical markets in 2002. At the first stage, the main priorities of Grand Medical Group included the selection of pharmaceutical products covering the needs of modern medicine, formation of a package of such products in view of the principal therapeutic directions, organization of the products manufacture in Western Europe and development of their registration dossiers for further introduction to the market and implementation into practical medicine.

Initially, Grand Medical Group targeted to introduce modern, effective and practically tested medical products to rapidly developing markets with new methods of therapy actively adopted to the health care system of the CIS countries. In 2012, a new period in the development of the company began: it was reorganized into a group of companies with 4 additional structural units for supervision of special sectors of the common business. Grand Medical Group AG, Switzerland is directly in charge for strategic coordination and management of all processes between the companies within the general structure.

The company’s portfolio has expanded due to complex products enabling effective and convenient control of a number of most critical pathogenetic factors at the same time. New products developed by Grand Medical Group® should increase the effectiveness of therapy for many significant urological, gynecological, neurological and gastroenterological diseases. New products are actively introduced not only to rapidly developing markets but also to mature markets of Central, Western and Southern Europe and Asia. Currently, GrandMedical Group® operates in Poland, Spain, Turkey, Romania and Albania.